Bausch Health Companies | VRX - Ativo Circulante





Ativo Circulante Alterar Data
Amgen USD 34.96B 3.49B 2026-06
ANI Pharmaceuticals USD 747.08M 6.03M 2026-03
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Bausch Health Companies USD 6.52B 544M 2026-06
Biogen USD 7.31B 1.88B 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Canopy Growth CAD 529.47M 4.8M 2026-03
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Danaher USD 13.38B 554M 2026-06
Drreddys Laboratories INR 301.98B 298.66B 2026-03
Eli Lilly USD 64.67B 9.84B 2026-06
Gilead Sciences USD 12.53B 6.11B 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Novo Nordisk DKK 208.7B 31.38B 2026-06
Pacira USD 615.21M 100.25M 2026-06
Perrigo USD 2.45B 260.7M 2026-06
Phibro Animal Health USD 894.07M 31.88M 2026-03
Prestige Brands USD 496.81M 65.33M 2026-06
Supernus Pharmaceuticals USD 723.5M 8.08M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06
Zoetis USD 6.47B 294M 2026-03